You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Details for New Drug Application (NDA): 062539

✉ Email this page to a colleague

« Back to Dashboard

NDA 062539 describes NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE, which is a drug marketed by Alcon Pharms Ltd and Pharmafair and is included in two NDAs. Additional details are available on the NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE profile page.

The generic ingredient in NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE is dexamethasone sodium phosphate; neomycin sulfate. There are thirty-nine drug master file entries for this compound. Additional details are available on the dexamethasone sodium phosphate; neomycin sulfate profile page.

Summary for 062539

Tradename:	NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE
Applicant:	Pharmafair
Ingredient:	dexamethasone sodium phosphate; neomycin sulfate
Patents:	0

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	SOLUTION/DROPS;OPHTHALMIC			Strength	EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML
Approval Date:	Jan 10, 1985	TE:		RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.